Christina Ornauer: Exploring the Latest Advances in Hematology at EHA 2026
Christina Ornauer, Vice President, Head of Medical Affairs of Hematology Europe at Avanzanite Bioscience, shared a post on LinkedIn:
“Attending EHA 2026 was truly inspiring, as I connected with dedicated colleagues, researchers, and healthcare professionals focused on advancing patient care.
The congress showcased the remarkable pace of innovation in hematology and emphasized the importance of collaboration within the healthcare community.
I am grateful for the opportunity to learn, exchange perspectives, and bring new insights back to my work.
Thank you to everyone who shared their expertise and passion throughout the meeting.
I look forward to seeing how these advances continue to shape the future for patients.”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge